Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 140,000 | reported | 09 Mar 2026 | tx 1+140,000 |
| PLIANT THERAPEUTICS, INC. | 26,764 | reported | 13 Jun 2024 | tx 4+69,050 |
| LENZ Therapeutics, Inc. | 20,000 | reported | 19 Jul 2023 | tx 4+139,467 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Mar 2026 | GRANT_AWARD | Lyell Immunopharma, Inc. | 140,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 26,764 | 0.00 USD | deriv |
| 19 Jul 2023 | GRANT_AWARD | LENZ Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 14,000 | 0.00 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | LENZ Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 15,000 | 0.00 USD | deriv |
| 29 Jun 2021 | PURCHASE | LENZ Therapeutics, Inc. | 5,882 | 17.00 USD | |
| 15 Apr 2021 | GRANT_AWARD | LENZ Therapeutics, Inc. | 93,585 | 0.00 USD | deriv |
| 29 Jun 2021 | GRANT_AWARD | PLIANT THERAPEUTICS, INC. | 13,286 | 0.00 USD | deriv |